US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Bluelinea SA (ALBLU) 銘柄情報

Bluelinea SA (ALBLU)

0.41

0.00

(0.00%)

終了 6月15日 12:30AM

Bluelinea SA (ALBLU) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.41

( - )

買値

0.40

売値

0.42

出来高

1,083

0.41 日の範囲 0.41

0.40 52 週間の範囲 0.69

時価総額

前日終値

0.41

始値

0.41

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,041 €

発行済株式数

18,421,012

配当利回り

PER

-5.14

1 株当たり利益 (EPS)

-0.08

歳入

11.12M

純利益

-1.51M

Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting c... Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting caregivers and staff in shared accommodation between seniors, serviced residences, EHPADs, specialized disability centers, and health establishments. Bluelinea Société Anonyme was incorporated in 2006 and is headquartered in Versailles, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.bluelinea.com

本社

Versailles, France

設立

2026

Bluelinea SA is listed in the Healthcare sector of the ユーロネクスト with ticker ALBLU. The last closing price for Bluelinea was 0.41 €. Over the last year, Bluelinea shares have traded in a share price range of 0.40 € to 0.69 €.

Bluelinea currently has 18,421,012 shares in issue. The market capitalisation of Bluelinea is 7.55 € million. Bluelinea has a price to earnings ratio (PE ratio) of -5.14.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-2.38095238095	0.42	0.42	0.41	746	0.41502513	DE
4	-0.04	-8.88888888889	0.45	0.46	0.4	2762	0.4116817	DE
12	-0.082	-16.6666666667	0.492	0.5	0.4	2467	0.43847138	DE
26	-0.05	-10.8695652174	0.46	0.515	0.4	1973	0.45819186	DE
52	-0.22	-34.9206349206	0.63	0.69	0.4	2178	0.50011527	DE
156	-1.035	-71.6262975779	1.445	1.45	0.4	2498	1.03690478	DE
260	-4.08	-90.868596882	4.49	5.2	0.4	2980	1.57659402	DE

ALBLU - Frequently Asked Questions (FAQ)

What is the current Bluelinea SA share price?

The current share price of Bluelinea SA is 0.41 €

How many Bluelinea SA shares are in issue?

Bluelinea SA has 18,421,012 shares in issue

What is the market cap of Bluelinea SA?

The market capitalisation of Bluelinea SA is EUR 7.55M

What is the 1 year trading range for Bluelinea SA share price?

Bluelinea SA has traded in the range of 0.40 € to 0.69 € during the past year

What is the PE ratio of Bluelinea SA?

The price to earnings ratio of Bluelinea SA is -5.14

What is the cash to sales ratio of Bluelinea SA?

The cash to sales ratio of Bluelinea SA is 0.7

What is the registered address of Bluelinea SA?

The registered address for Bluelinea SA is 2-12 Parvis Colonel Arnaud Beltrame, Versailles, Ile-de-France, 78000

What is the Bluelinea SA website address?

The website address for Bluelinea SA is www.bluelinea.com

Which industry sector does Bluelinea SA operate in?

Bluelinea SA operates in the Medical Equipment & Supplies sector

stocup

Nah, I sold ant 1.18 and bought back my Lightwave shares. I think it’ll pay off, we’ll see. Good luck to you

Augster

Augster 5分前

gitreal

gitreal 5分前

Perhaps it's a scam? Maybe?

tombe

Possible potential buyer was able to have a voice in that decision?

Krombacher

Krombacher 8分前

**Why Shorting a Sub-Penny Stock Takes Serious Money — and What It Might Mean for $RDAR**
*(Speculation clearly labeled. This leans on mechanics, RDAR's public filings, announcements, and share structure rather than unproven claims. Happy to have it torn apart with facts.)*

*

tombe

“Seemed to guarantee “. Please provide statements made to support that claim. You seem to have a very fake king/Ib way about you.

learningcurve2020

learningcurve2020 9分前

I haven’t listened to all the episodes but can’t find a mention of Les’ passing anywhere on the Big Biz Show?? You’d think given his many appearances and their audience of loyal followers, they’d say something. 🤷‍♀️

Mr. Dragon

Mr. Dragon 9分前

Mwood1, Mwood1, Mwood1, Mwood1

bobby1151

bobby1151 9分前

And no talk about Bioelectronics Vagus Nerve Patent Pending & it's tremendous impact it could have for Biel shareholder's!!

gutek

Dump and dilute Concepts.

t1215s

t1215s 11分前

Well I said this a very long time, ago also recently “BIG MONIES,DON’T LIKE TO PART WITH BIG MONIES ,remember that word” COLORFUL” hmmm, and maybe many would have gotten caught with their fingers in the humungous cookie jar which is why possibly the silence isss deafening and they were happy with wh

learningcurve2020

learningcurve2020 12分前

Why aren’t you upset that LP hasn’t sold the company to someone with know how and big money to get things moving?

Sammy boy

Sammy boy 13分前

So I wonder if Iran upholds its 4th promise?

BigBadWolf

BigBadWolf 13分前

Just to inform the uninformed, Patent applications do not prevent scientific peer review; in fact, they require absolute, granular disclosure of how an invention works to be granted. Furthermore, independent verification of a working prototype can easily be done under strict Non-Disclosure Agreement

SSKILLZ1

SSKILLZ1 16分前

This was the game brunson had to kind of take them on the back and get them to the finish line, because his team at least offensively didn't have it yesterday that is painfully obvious last night in my opinion.

Rosym

Nio Dominates All 4, Don't Allow The Propaganda Machine To Shake You

A Weibo blogger with over half a million followers just posted pictures of NIO's F2 factory in Hefei, and the lot is absolutely packed.
Over 2,000 freshly built vehicles are staged wall to wall.
ES8s

learningcurve2020

learningcurve2020 19分前

If you’re such a great investor why don’t you tell us about L Specials program track record? What are they telling the very few who sign up for it?

>>In my opinion the drug we are supporting is beneficial to fight many cancers. To me it’s undisputed.

boston127

boston127 20分前

Looks to me that Emil has not

been working this as diligently as he should have been. Looks like Monday is the day we find out if we have an ongoing company to invest in. What a slap in the face this is:

Due to the time delay and inadequacy of the materials provided t

MONTI KING

MONTI KING 20分前

Definitely a problem with all otc CEO’s… however .. at least he is consistent and never says anything .. even when asked on his YouTube channel .. all he has ever said is that he can confirm that he is CEO OF VGLS.. while other CEO’s will pump and dilute.. rinse and repeat . Then dead silence .. the

CatfishHunter

CatfishHunter 21分前

Vivos issued IDE submission PR June 5th. I think they submitted by COB the day before, June 4th. To be safe, using June 5th as submission date, the 30 day clock expires July 6th. Once Vivos receives notice of decision, they have 4 business days to notify shareholders. So theoretically last day

02opida

02opida 21分前

Go Billionaires' To find Godlen Tickers

02opida

02opida 22分前

02opida

02opida 23分前

02opida

02opida 23分前

02opida

02opida 23分前

FTSEurofirst 300 Eurozon...

Colruyt Group NV

Crypto Blockchain Indust...

Japan Aviation Electr (PK)

TXT E Solutions

Saja Real Estate Socimi

Government/treasury guar...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。